Vendeix Sirga Advanced Biopharma, Inc. · R&D PhD ContactConnect with experts in your field Join ResearchGate to contact this researcher and connect with your scientific community. Join for...
Home Max Planck Institute for Biophysical Chemistry Department of Physical Biochemistry Namit Ranjan Namit Ranjan Max Planck Institute for Biophysical Chemistry | MPIBPC · Department of...
Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis ; Michal Czeslaw Piotrowicz ; Benzoxazepine-Derived, Selective, Orally Bioavailable Inhibitor of Human Acidic Mammalian Chitinase ; Bioorg. & Med. Chem. Lett., 2018, 28, 310-314_si.docx
Home Uppsala University Department of Medical Biochemistry and Microbiology Joakim Näsvall Joakim Näsvall Uppsala University | UU · Department of Medical Biochemistry and Microbiology...
Home The University of Tokyo Faculty & Graduate School of Engineering Kenjyo Miyauchi Kenjyo Miyauchi The University of Tokyo | Todai · Faculty & Graduate School of Engineering PhD...
About Publications 29 Network About 29 Publications 1,362 Reads 430 Citations Featured research Diversity in Fosfomycin Resistance Proteins Article Full-text available Dec 2014 Matthew K...
Abstract : The present invention relates to diaminotriazine compounds and to their use as herbicides. The present invention also relates to agrochemical compositions for crop protection and to a method for controlling unwanted vegetation. Formula (I) wherein A is a fused saturated or unsaturated, 5-, 6-membered carbocycle or a fused saturated or unsaturated, 5-, 6-membered heterocycle; p is 1 or 2, q is 0, 1, 2 or 3; Rb is inter alia halogen, OH, CN, amino, NO 2, C1-C6-alkyl, C2-C6-alkenyl, C2-C 6-alkynyl, C 1-C6-alkoxy, C2-C6-alkenyloxy, C2-C6 ...
Description ; The present application claims the benefit of U.S. Provisional Application No. 60/669,872, filed Apr. 11, 2005, which application is herein incorporated by reference in its entirety. A paper copy of the Sequence Listing submitted herewith is herein incorporated by reference. The present invention relates generally to replicase complex defect inducers and pharmaceutical compositions containing such inducers. Methods of developing mutants that are resistant to replicase complex defect inducers are ...
Substituted benzyloxypyrimidines and their inactivation of O6 -alkylguanine-DNA alkyltransferase Abstract The present invention provides certain novel nitro or nitroso substituted benzyloxy...
Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines Abstract The present invention provides 8-substituted O 6 -benzylguanines of the formula ##STR1## wherein R 1 , R 2 , and R 3 are...